Contact us   |  

Impact of treatments on quality of life

Impact of treatments on quality of life

18/10/2021 17:00

Speakers: Pietro Quaglino, Keturah Harris

Target: Patients
Subnetworks: Lymphoid malignancies
Disease Groups: Primary cutaneous lymphoma

Pietro Quaglino born 1968, dermatologist, is Associate Professor of Dermatology at the Department of Medical Sciences, University of Turin Medical School. He obtained the National Scientific Qualification as Full Professor in 2013. He is now Director of the Residency Programme in Dermatology at the University of Turin.

His main field of interest for clinical and research activities are cutaneous lymphoma, melanoma,  and immune dermatology. His experience in the field of cutaneous lymphoma ranges from the early diagnosis to the treatment of the advanced phase disease. He is the principal investigator of several clinical trials in melanoma and cutaneous lymphoma. He is past-chairman of the EORTC Cutaneous Lymphoma Task Force and has been member of the Board Directors of the ISCL (International Society for Cutaneous Lymphoma) board member of the GIPMe (Gruppo Italiano Polidisciplinare sul Melanoma), board member and treasurer since 2017 of the IMI (Italian Melanoma Intergroup). He has published more than 200 peer-reviewed scientific papers.Prof. Quaglino is Assistant Editor of the Giornale Italiano di Dermatologia e Venereologia, reviewer of international journals on dermatology and referee for ANVUR (National Agency for the Evaluation of Universities and Research Institutes).

Keturah Harris is an award-winning inspirational author, business consultant and career strategist.   She holds an MBA in change management as well as certifications including Human Resource Management, Spiritual Care and Psychotherapy.

In 2013, she received a diagnosis of Cutaneous T-Cell Lymphoma Mycosis Fungoides. She has been on a path of life-altering treatment for this condition since this time.   Soon after her diagnosis, she was fortunate to discover the Cutaneous Lymphoma Foundation (CLF).  Through CLF she has been able to connect with CLF patients, preview the latest research and access the expertise from medical specialists in this field.  

Keturah currently resides in Ontario Canada where she serves on a regional Patient and Family Advisory Committee advocating for patients who are immunocompromised or living with disability. Her desire is to authentically share her experience in the hopes that it will enlighten practitioners and encourage patients.